Table 5.
Comparison of the chemotherapy-treated group (neoadjuvant and adjuvant) and the non-chemotherapy group in terms of fatigue at all measurement stages using the Mann-Whitney U test.
| Group receiving neoadjuvant chemotherapy (N = 6) Median | Group not receiving neoadjuvant chemotherapy (N = 15) Median | U | Z | p | ||
|---|---|---|---|---|---|---|
| FACIT-F |
Measurement 1 | 17.5 | 18.0 | 39.00 | 0.43 | 0.67 |
| Measurement 2 | 15.5 | 25.0 | 30.50 | 1.09 | 0.27 | |
| Measurement 3 | 16.5 | 23.0 | 25.5 | 1.48 | 0.14 | |
| Measurement 4 |
18.0 |
18.0 |
42.5 |
0.16 |
0.16 |
|
| Group receiving adjuvant chemotherapy (N = 7) Median | Group not receiving adjuvant chemotherapy (N = 14) Median | U | Z | p | ||
| FACIT-F | Measurement 1 | 18.0 | 17.5 | 51.00 | 0.18 | 0.86 |
| Measurement 2 | 25.0 | 22.5 | 52.50 | 0.07 | 0.94 | |
| Measurement 3 | 21.0 | 18.0 | 51.5 | 0.14 | 0.89 | |
| Measurement 4 | 19.0 | 16.5 | 51.5 | 0.14 | 0.89 | |
*p < 0.05 Z – standardised value, U – rank sum.